Dr. Naveen Chandra G SHOD and Lead Consultant - Department of Interventional Cardiology, Aster Whitefield Hospital, Bengaluru ...

The protocols offer a more accurate way to detect atherosclerosis and assess cardiovascular risk before symptoms appear, ...

A drug candidate, previously successful at treating severe fatty liver disease, reduces atherosclerosis—a primary driver of ...

A drug candidate, previously successful at treating severe fatty liver disease, reduces atherosclerosis - a primary driver of cardiovascular death worldwide - in large mammals, a study suggests.

Atherosclerosis is when plaque forms in the arteries. This can lead to blood clots that may suddenly stop blood supply; when this affects the heart's... | Clinical And Molecular Dx ...

A drug candidate, previously successful at treating severe fatty liver disease, reduces atherosclerosis—a primary driver of cardiovascular death worldwide—in large mammals, a study suggests.

One of the most common signs that arteries might be blocked is chest pain, often called angina. People often describe it as a ...